FindTrial
Sign In

AP301 Low Dose

DRUG2 trials

Sponsors

Alebund Pharmaceuticals

Conditions

Chronic Kidney Disease(CKD)Chronic Kidney Disease, Receiving DialysisDialysisESRD (End Stage Renal Disease)ESRD (End-Stage Renal Disease)HyperphosphatemiaHyperphosphatemia in Chronic Kidney Disease

Phase 3

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
RecruitingNCT06933472
Alebund PharmaceuticalsChronic Kidney Disease, Receiving Dialysis, Dialysis, ESRD (End-Stage Renal Disease) +1
Start: 2025-06-13End: 2027-01-10Target: 264Updated: 2026-01-29
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
CompletedNCT07030595
Alebund PharmaceuticalsChronic Kidney Disease(CKD), Chronic Kidney Disease, Receiving Dialysis, Dialysis +3
Start: 2023-06-12End: 2025-05-30Updated: 2025-11-17